Michael Craig Miller

Author

Also Known As

M C Miller, M C. Miller, M Craig Miller, M Miller, M. C. Miller, M. CRAIG MILLER, M. Craig Miller, M. Miller, M.C. Miller, M.Craig Miller

277

Publications

23.5K

Citations

H-Index

117

Concepts

All Affiliations

Johns Hopkins University The University of Texas MD Anderson Cancer Center Eon Corporation (United States)Brown University Johns Hopkins Medicine

About

Michael Craig Miller is an author at Johns Hopkins University specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	44	6.4K
2	Public Health	5	5	154
3	Health Sciences	4	4	182
4	Engineering	3	3	322
5	Law	1	1	16

Michael Craig Miller

Publications

22.9K

Citations

H-Index

Page 1

	Year	Citations
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis, New England Journal of Medicine	2004	4.5K
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases W. Jeffrey Allard, Jeri Matera, Michael Craig Miller, Clinical Cancer Research	2004	2.5K
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer Johann S. de Bono, Howard I. Scher, Bruce Montgomery, Clinical Cancer Research	2008	2.2K
Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer Steven J. Cohen, Cornelis J.A. Punt, Nicholas Iannotti, Journal of Clinical Oncology	2008	1.8K
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer Massimo Cristofanilli, Daniel F. Hayes, G. Thomas Budd, Journal of Clinical Oncology	2005	1.1K
Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival Daniel F. Hayes, Massimo Cristofanilli, G. Thomas Budd, Clinical Cancer Research	2006	1K
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass Richard G. Moore, D. Scott McMeekin, Amy Brown, Gynecologic Oncology Cancer DetectionMedicinePelvic MassPathologyGynecology	2008	852
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer G. Thomas Budd, Massimo Cristofanilli, Mathew J. Ellis, Clinical Cancer Research	2006	787
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer Michael Craig Miller, Gerald V. Doyle, Leon W.M.M. Terstappen Journal of Oncology Breast OncologyCtc DefinitionCirculating Tumor CellsCancer ManagementCellsearch System	2009	753
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass Richard G. Moore, Amy Brown, Michael Craig Miller, Gynecologic Oncology Cancer DetectionMedicinePelvic MassGynecologyPathology	2007	686

Page 1